The Relationship Between Symptom Severity and Chemotherapy Protocols for Breast and Lung Cancer Chemotherapy Patients

2.50
Hdl Handle:
http://hdl.handle.net/10755/161012
Type:
Presentation
Title:
The Relationship Between Symptom Severity and Chemotherapy Protocols for Breast and Lung Cancer Chemotherapy Patients
Abstract:
The Relationship Between Symptom Severity and Chemotherapy Protocols for Breast and Lung Cancer Chemotherapy Patients
Conference Sponsor:Midwest Nursing Research Society
Conference Year:2007
Author:Keehne-Miron, Jackie, RN, MSN, AOCN
P.I. Institution Name:Michigan State University
Contact Address:, Sparta, MI, 49345, USA
Co-Authors:A. Sikorskii, B. Given, and C.W. Given, College of Nursing, Michigan State University, East Lansing, MI
Purpose: The purpose of this study was to determine if chemotherapy protocol influences severity of symptoms that breast and lung cancer patients experience after controlling for age, co-morbid conditions and intervention vs. control group membership. Background / Methods: Interviews conducted at baseline (within the first 2 cycles of chemotherapy), post-intervention at 10 weeks and at 20 weeks, as well as a medical record audit served as the method of data collection. A behavioral-cognitive nursing intervention was implemented after random assignment. The intervention focused on assisting patients to obtain self-care management knowledge, skills and behaviors to best manage cancer/chemotherapy symptoms. Two comprehensive cancer centers and four community oncology sites in Michigan and Connecticut were used for this study. Secondary data analysis were conducted on the sample of 71 females with breast cancer, 21 females with lung cancer and 23 men with lung cancer who completed the 20 week interview. Results: Chemotherapy protocol failed to exhibit an association with symptom severity at 20 weeks, however, membership in the experimental group as well as the presence of co-morbid conditions at baseline were related to symptom severity at 20 weeks. Symptoms related to toxicity profiles (i.e., nausea, mucositis, fever, diarrhea) of the chemotherapy protocols were not as prevalent as symptoms linked to the chemotherapy experience (i.e., fatigue, pain, insomnia). Implications: These data support the need to refocus our attention to symptoms that are not only representative of the chemotherapy agents, but, in addition, the symptoms representing the cancer/chemotherapy experience. The cognitive-behavioral nursing intervention implemented in this study did impact symptom severity positively. This study also supports the need to assess and monitor co-morbid conditions due to their relationship with symptom severity.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Midwest Nursing Research Society

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleThe Relationship Between Symptom Severity and Chemotherapy Protocols for Breast and Lung Cancer Chemotherapy Patientsen_GB
dc.identifier.urihttp://hdl.handle.net/10755/161012-
dc.description.abstract<table><tr><td colspan="2" class="item-title">The Relationship Between Symptom Severity and Chemotherapy Protocols for Breast and Lung Cancer Chemotherapy Patients</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Midwest Nursing Research Society</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2007</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Keehne-Miron, Jackie, RN, MSN, AOCN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Michigan State University</td></tr><tr class="item-address"><td class="label">Contact Address:</td><td class="value">, Sparta, MI, 49345, USA</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">jkeehne@amgen.com</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">A. Sikorskii, B. Given, and C.W. Given, College of Nursing, Michigan State University, East Lansing, MI</td></tr><tr><td colspan="2" class="item-abstract">Purpose: The purpose of this study was to determine if chemotherapy protocol influences severity of symptoms that breast and lung cancer patients experience after controlling for age, co-morbid conditions and intervention vs. control group membership. Background / Methods: Interviews conducted at baseline (within the first 2 cycles of chemotherapy), post-intervention at 10 weeks and at 20 weeks, as well as a medical record audit served as the method of data collection. A behavioral-cognitive nursing intervention was implemented after random assignment. The intervention focused on assisting patients to obtain self-care management knowledge, skills and behaviors to best manage cancer/chemotherapy symptoms. Two comprehensive cancer centers and four community oncology sites in Michigan and Connecticut were used for this study. Secondary data analysis were conducted on the sample of 71 females with breast cancer, 21 females with lung cancer and 23 men with lung cancer who completed the 20 week interview. Results: Chemotherapy protocol failed to exhibit an association with symptom severity at 20 weeks, however, membership in the experimental group as well as the presence of co-morbid conditions at baseline were related to symptom severity at 20 weeks. Symptoms related to toxicity profiles (i.e., nausea, mucositis, fever, diarrhea) of the chemotherapy protocols were not as prevalent as symptoms linked to the chemotherapy experience (i.e., fatigue, pain, insomnia). Implications: These data support the need to refocus our attention to symptoms that are not only representative of the chemotherapy agents, but, in addition, the symptoms representing the cancer/chemotherapy experience. The cognitive-behavioral nursing intervention implemented in this study did impact symptom severity positively. This study also supports the need to assess and monitor co-morbid conditions due to their relationship with symptom severity.</td></tr></table>en_GB
dc.date.available2011-10-26T23:14:28Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T23:14:28Z-
dc.description.sponsorshipMidwest Nursing Research Societyen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.